A clinical study on CD33-directed chimeric antigen receptormodified NKcells in patient with refractory or relapsed acute myeloid leukemia

被引：1
|
作者：
Xia, Leiming [1 ]
Sun, Xiang [1 ]
Liu, Liu [1 ]
Wang, Yi [1 ]
Li, Tan [1 ]
Li, Bin [1 ]
Wolf, Gregory [2 ]
Li, Qiao [2 ]
Yang, Lin [3 ]
Bao, Yangyi [1 ]
机构：
[1] First Peoples Hosp Hefei, Hefei, Anhui, Peoples R China
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Persongen Biomed, Suzhou, Peoples R China
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
Refractory or relapsed acute myeloid leukemia (R/R AML); CD33; Chimeric antigen receptor (CAR); NK cells; Immunotherapy;
D O I：
10.1158/1538-7445.AM2018-CT060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT060
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Fletcher, Theresa
    Hawkins, Emily R.
    Cashen, Amanda
    DiPersio, John F.
    Jacoby, Meagan A.
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 728 - 730
  • [42] Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis
    Shahzad, Moazzam
    Nguyen, Andrea
    Hussain, Ali
    Ammad-Ud-Din, Mohammad
    Faisal, Muhammad Salman
    Tariq, Ezza
    Ali, Fatima
    Butt, Atif
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Lutfi, Forat
    Ahmed, Nausheen
    Singh, Anurag K. K.
    Hematti, Peiman
    McGuirk, Joseph P. P.
    Mushtaq, Muhammad Umair
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Shahzad, Moazzam
    Chaudhary, Sibgha Gull
    Hussain, Ali
    Ali, Fatima
    Khalid, Ayesha
    Tariq, Ezza
    Zafar, Muhammad Usman
    Arslan, Muhammad
    Anwar, Iqra
    Bansal, Rajat
    Hematti, Peiman
    Lin, Tara L.
    Abhyankar, Sunil
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    BLOOD, 2021, 138
  • [44] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
  • [45] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
    Canaani, Jonathan
    Danylesko, Ivetta
    Shemtov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
  • [46] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Canaani, Jonathan
    Danilesko, Ivetta
    Shem-Tov, Noga
    Zlotnick, Maya
    Lozinsky, Kira
    Benjamini, Ohad
    Yerushalmi, Ronit
    Nagar, Meital
    Dor, Chen
    Shimoni, Avichai
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2020, 136
  • [47] Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia
    Bieker, R
    Lerchenmüller, C
    Wehmeyer, J
    Serve, HL
    Mesters, RM
    Büchner, T
    Berdel, WE
    ONCOLOGY REPORTS, 2003, 10 (04) : 915 - 920
  • [48] Clinical Study on the CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Acute Lymphoblast Leukemia: A Single Center of Real World Data
    Huang, Jing
    Liu, Zhi
    Ou, Ruiming
    Zheng, Liling
    Zhu, Yangmin
    Du, Yuanyuan
    Zhou, Qinjun
    Fei, Jia
    Liu, Shuang
    Zhang, Qing
    BLOOD, 2021, 138
  • [49] Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
    Pizzitola, I.
    Anjos-Afonso, F.
    Rouault-Pierre, K.
    Lassailly, F.
    Tettamanti, S.
    Spinelli, O.
    Biondi, A.
    Biagi, E.
    Bonnet, D.
    LEUKEMIA, 2014, 28 (08) : 1596 - 1605
  • [50] Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo
    I Pizzitola
    F Anjos-Afonso
    K Rouault-Pierre
    F Lassailly
    S Tettamanti
    O Spinelli
    A Biondi
    E Biagi
    D Bonnet
    Leukemia, 2014, 28 : 1596 - 1605
12345